PRESS RELEASE TiGenix announces partial conversion of bonds Leuven BELGIUM November 6 2017 700h CET TiGenix NV Euronext Brussels and NASDAQ TIG an advanced biopharmaceutical company focused on exploiting the antiinflammatory properties of allogenei...
↧